Langford et al. Abatacept NOT effective in GPA in ABROGATE RCT. 65 patients. Relapse/worsening in 62% vs 68%. No differe

Social Author Image

https://pbs.twimg.com/profile_images/1389468430160510976/sooz0Ud3_normal.jpg

Tweet Author

Social Author Name

Richard Conway

Tweet Content

Langford et al. Abatacept NOT effective in GPA in ABROGATE RCT. 65 patients. Relapse/worsening in 62% vs 68%. No difference in any secondary end-point. @RheumNow #ACR24 Abstr#0823 https://t.co/yRFZ2diJFF https://t.co/LgXkPnDArE

Links

A Randomized, Double-Blind, Placebo-Controlled Trial of Abatacept for the Treat… https://acrabstracts.org/abstract/a-randomized-double-blind-placebo-controlled-…

https://x.com/RichardPAConway/status/1857848106349412762/photo/1

Show on Archive Page

On

Display in Search Results

On

PDQ

Off

Topics

Langford et al. Abatacept NOT effective in GPA in ABROGATE RCT. 65 patients. Relapse/worsening in 62% vs 68%. No differe

Do you get our email newsletter?